Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …

Alzheimer's disease (AD) and COVID-19 share many common risk factors, such as
advanced age, complications, APOE genotype, etc. Epidemiological studies have also …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to …

Although no longer considered a public health threat, post‐COVID cognitive syndrome
continues to impact on a considerable proportion of individuals who were infected with …

Increasingly prevalent acute and chronic human brain diseases are scourges for the elderly.
Besides the lack of therapies, these ailments share a neuroinflammation that is …

On the last day of the year 2019 a novel Betacoronavirus (2019-nCov), now known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …

During the last three years, since the emergence of the COVID-19 pandemic, a significant
number of scientific publications have focused on resolving susceptibility to the infection, as …

Abstract The coronavirus (COVID-19) pandemic, caused by severe acute respiratory system
coronavirus 2 (SARS-CoV-2), has created significant challenges for scientists seeking to …

The single-stranded viral RNA (ssvRNA) known as the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) that causes COVID-19 can be effectively inactivated by a …

Alzheimer's disease (AD) is a life-changing condition whose etiology is explained by several
hypotheses. Recently, a new virus contributed to the evidence of viral involvement in AD: the …